Digital Content 
NEWS #PharmaBuzz
11 Jun 2025
// INDPHARMAPOST
https://www.indianpharmapost.com/news/glenmark-pharmaceuticals-to-launch-dcgi-approved-brukinsa-in-india-for-treatment-of-hematological-malignancies-17261
31 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250531886517/en/BeOne-Medicines-Presents-New-SEQUOIA-Study-Results-Reinforcing-BRUKINSAs-Differentiated-Profile-with-or-without-Venetoclax-in-Frontline-CLL-at-ASCO-2025
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522213317/en/BeiGene-Presents-Pioneering-Cancer-Research-at-ASCO-2025-Redefining-Treatment-Across-Hematology-and-Solid-Tumors
14 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250514394684/en/BeiGene-Showcases-Strength-of-Hematology-Portfolio-at-EHA-2025-with-New-Data-Highlighting-BRUKINSAs-Leadership-and-Next-Generation-Innovation
29 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250429590949/en/U.S.-Patent-and-Trademark-Office-Invalidates-Pharmacyclics-Patent-Asserted-Against-BeiGene
20 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/20/3029678/0/en/SELLAS-Announces-Positive-Data-from-Phase-2a-Trial-of-SLS009-in-Combination-with-Zanubrutinib-in-DLBCL.html
Share 